November 24, 2021
According to a research report titled ‘Global Clinical Trial Management Market 2021-2028’, available with MarketStudyReport, global clinical trial management market is expected to register a CAGR of 10.92% over 2021-2028.
Alarming rise in the pool of chronic disease patients, surging R&D activities in the medical sector, and benefits offered by CTM software are the primary growth catalysts for global clinical trial management market. Moreover, increasing clinical trials, along with the option of outsourcing these services for cost reduction is creating new opportunities for the industry.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3754658/
On the downside, concerns about security of CTM systems, high initial implementation cost, along with huge expenses of deploying & maintaining CTM software have compelled the researchers and pharmaceutical corporations to reconsider investing in these systems, hence impeding industry growth.
On the basis of deployment mode, the market is categorized into web-based deployment, cloud-based deployment, and on-premise deployment. Based on component terrain, global clinical trial management market is classified into software, hardware, and services.
In terms of product type, the industry is segmented into enterprise based CTM, and site based CTM. With respect to end user gamut, the marketplace is branched into clinical research organizations, healthcare providers, and pharmaceutical & biopharmaceutical companies.
Considering the regional outlook, the market spans across North America, Asia-Pacific, Latin America, Europe, and Middle East & Africa. Among these, Asia Pacific is predicted to become lucrative avenue for the market during the forecast period. The expansion is attributed to large population base, increasing awareness about clinical trial management products, and improving healthcare vertical with focus on R&D activities.
The prominent players in global clinical trial management market include Parexel International Corporation, BioClinica Inc., Oracle Corporation, IBM Corporation, Advarra Inc., Bio-Optronics Inc., Mednet Solutions Inc., Veeva Systems Inc., Arisglobal LLC, and Medidata Solutions.